Dr. Mia Levy on Informatics to Support Genome Directed Cancer Medicine, Dec. 12

Synopsis:

Genome directed cancer therapy holds great promise for the future of cancer treatment, however many challenges remain.  This talk will review the informatics challenges and solutions related to the Vanderbilt Personalized Cancer Medicine Initiative.  Dr. Mia Levy will present our initial solution including how tumor gene mutation testing results were integrated into the electronic health record with a link to a decision support knowledge service to assist providers in understanding actionable gene directed therapies including local and national clinical trials.  The resource called My Cancer Genome is now publicly available at MyCancerGenome.org. Dr. Levy will describe the development and maintenance of this application including the annotation of the National Cancer Institute PDQ clinical trial registry with gene associations.  

Bio:

Dr. Mia A. Levy is the Ingram Assistant Professor of Cancer Research, an Assistant Professor of Biomedical Informatics and Medicine, and the Director of Cancer Clinical Informatics for the Vanderbilt-Ingram Cancer Center.

Dr. Levy received her undergraduate degree in Bioengineering from The University of Pennsylvania in 1997 and her Medical Doctorate from Rush University in 2003. She then spent six years at Stanford University completing post-graduate training in Internal Medicine and Medical Oncology while completing her PhD in Biomedical Informatics. She joined the faculty at Vanderbilt as an Assistant Professor in Biomedical Informatics and Medicine in August 2009. She is a practicing medical oncologist specializing in the treatment of breast cancer.